The value of pre-symptomatic genetic risk assessment for age-related macular degeneration: the Moran AMD Genetic Testing Assessment (MAGENTA) study-a study protocol for a randomized controlled trial.
Emmanuel Kofi AddoM Elizabeth HartnettPaul S BernsteinPublished in: Trials (2023)
ClinicalTrials.gov NCT05265624 . Registered on March 3, 2022.